ArticleThe Journal of investigative dermatology2015
Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study.
Sarbjit S Saini et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
32 papers cite it
this paperpooled itcites it